129 related articles for article (PubMed ID: 9770967)
1. [Antisecretory effects of quamatel and gastrocepin in duodenal ulcer: comparison with intragastric pH-metry].
Sheptulin AA; Okhlobystin AV
Klin Med (Mosk); 1998; 76(8):38-40. PubMed ID: 9770967
[TBL] [Abstract][Full Text] [Related]
2. [Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].
Rakov AL; Makarov IuS; Gorbakov VV; Mironenko DA; Golochalova TV
Voen Med Zh; 2001 Sep; 322(9):54-8. PubMed ID: 11668793
[No Abstract] [Full Text] [Related]
3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
4. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
[No Abstract] [Full Text] [Related]
5. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Evseev MA; Ivakhov GB; Golovin RA
Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
[No Abstract] [Full Text] [Related]
6. [Study on the efficacy of famotidine (Quamatel) in the complex treatment of erosive gastroduodenitis, stress stomach ulcer and peptic duodenal ulcer].
Korukov B; Ognianov S; Kostadinova R; Gerzilov P; Ivanov A; Iarŭmov N
Khirurgiia (Sofiia); 2004; 60(1):4-7. PubMed ID: 15704743
[TBL] [Abstract][Full Text] [Related]
7. [The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Vakhrushev IaM; Muravtseva OV
Eksp Klin Gastroenterol; 2002; (2):29-31, 101. PubMed ID: 12046381
[TBL] [Abstract][Full Text] [Related]
8. [Famotidine (quamatel) for treatment of ulcer disease].
Bogachev RS; Levina ZK
Khirurgiia (Mosk); 1999; (1):34. PubMed ID: 10050509
[No Abstract] [Full Text] [Related]
9. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
10. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
11. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
[TBL] [Abstract][Full Text] [Related]
12. [Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease].
Vakhrushev IaM; Muravtseva OV
Ter Arkh; 2006; 78(2):35-8. PubMed ID: 16613094
[TBL] [Abstract][Full Text] [Related]
13. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
[TBL] [Abstract][Full Text] [Related]
14. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
15. A single nocte dose of famotidine in the treatment of duodenal ulcer.
Qureshi H; Ahmad W; Zuberi SJ
J Pak Med Assoc; 1989 Apr; 39(4):104-6. PubMed ID: 2568508
[TBL] [Abstract][Full Text] [Related]
16. Duration of acid suppression in H2-antagonist nonresponders.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Celle G
Digestion; 1992; 51(4):185-92. PubMed ID: 1356863
[TBL] [Abstract][Full Text] [Related]
17. [The influence of antisecretory agents on the antral gastric mucosa in patients with duodenal ulcer].
Rapoport SI; Raĭkhlin NT; Khutsishvili MB; Rasulov MI; Antonenko NI
Klin Med (Mosk); 2006; 84(7):32-5. PubMed ID: 16924798
[TBL] [Abstract][Full Text] [Related]
18. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of the combination of gallic acid and famotidine in protection of rat gastric mucosa.
Asokkumar K; Sen S; Umamaheswari M; Sivashanmugam AT; Subhadradevi V
Pharmacol Rep; 2014 Aug; 66(4):594-9. PubMed ID: 24948059
[TBL] [Abstract][Full Text] [Related]
20. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
Alekseenko SA; Timoshin SS
Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
